DARE
NASDAQ
US
Dare Bioscience, Inc. - Common Stock
$1.74
▼ $-0.16
(-8.42%)
Vol 94K
5
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$27.6M
ROE
-124.7%
Margin
-28678.5%
D/E
254.24
Beta
0.94
52W
$2–$9
Wall Street Consensus
10 analysts · Apr 20262
Strong Buy
7
Buy
1
Hold
0
Sell
0
Strong Sell
90.0%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 80.0%
Next Report
May 11, 2026
EPS Estimate: $-0.36
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-0.36 | — | — |
| Dec 2025 | $-0.44 | $-0.02 | +$0.42 |
| Sep 2025 | $-0.36 | $-0.28 | +$0.08 |
| Jun 2025 | $-0.59 | $-0.45 | +$0.14 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… |
|---|---|---|---|---|---|
| Revenue | $42K | -$64K | $25K | -$21K | $2K |
| Net Income | -$4.7M | -$5.5M | -$4.4M | -$4.0M | -$3.6M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | — | 483.3% | 483.3% | 483.3% | 483.3% | -124.7% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | 4276.3% | 4276.3% | 4276.3% | 4276.3% | -28678.5% |
| Gross Margin | — | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| D/E Ratio | — | 0.00 | 0.00 | 0.00 | 0.00 | 254.24 |
| Current Ratio | 0.34 | 0.56 | 0.34 | 0.34 | 0.34 | 1.18 |
Key Ratios
ROA (TTM)
-56.5%
P/S (TTM)
995.96
P/B
6.3
EPS (TTM)
$-1.47
CF/Share
$-0.48
52W High
$9.19
52W Low
$1.61
$1.61
52-Week Range
$9.19
Financial Health
Free Cash Flow
-$617K
Net Debt
-$20.1M
Cash
$23.1M
Total Debt
$2.9M
As of Sep 30, 2025
How does DARE compare to Pharmaceuticals peers?
Peer group: Micro-cap Pharmaceuticals (All) · 171 companies
DARE valuation vs Pharmaceuticals peers
P/E ratio
—
▼
0%
below
peers
(22.4)
vs Peers
vs Industry
Undervalued
P/S ratio
996.0
▲
20020%
above
peers
(5.0)
vs Peers
vs Industry
Overvalued
P/B ratio
6.3
▲
199%
above
peers
(2.1)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(2.0%)
vs Peers
vs Industry
Low yield
DARE profitability vs Pharmaceuticals peers
ROE
-124.7%
▼
130%
below
peers
(-54.3%)
vs Peers
vs Industry
Weak
Net margin
-28678.5%
▼
60442%
below
peers
(-47.4%)
vs Peers
vs Industry
Weak
Gross margin
100.0%
▲
46%
above
peers
(68.3%)
vs Peers
vs Industry
Below avg
ROA
-56.5%
▼
51%
below
peers
(-37.4%)
vs Peers
vs Industry
Below avg
DARE financial health vs Pharmaceuticals peers
D/E ratio
254.2
▲
16409%
above
peers
(1.5)
vs Peers
vs Industry
High debt
Current ratio
1.2
▼
65%
below
peers
(3.4)
vs Peers
vs Industry
Low liquidity
Beta
0.9
▼
0%
below
peers
(0.9)
vs Peers
vs Industry
Less volatile
DARE fundamentals radar
DARE
Peer median
Industry
DARE profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
DARE vs peers: key metrics
Top Holders
Top 5: 5.37%Vanguard Group Inc
3.66%
$811K
Geode Capital Management, L…
0.83%
$184K
Susquehanna International G…
0.49%
$109K
Two Sigma Investments, LP
0.23%
$51K
State Street Corporation
0.16%
$36K
As of Dec 31, 2025